🌍23 centres are now opened to recruitment in France, The UK, Germany, the Czech Republic, Spain and the Netherlands.🏥
2 additional sites will follow at the beginning of 2026.👩⚕️
About 180 patients have been recruited so far in the trial, and a strong effort is being made by all teams involved for this unique randomized controlled trial (RCT) of its kind worldwide to reach its targets and develop a novel approach to treat cardiovascular diseases.🫀🩺💉
The study has already generated considerable interest within the international cardiology and immunology communities, and has the potential to substantially impact the economic burden of cardiovascular diseases through the validation of a new cost-effective therapy.🏆